trial · primary record
Donidalorsen
Hereditary Angioedema (HAE)
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2029-06 |
| Primary endpoint | Number of Participants with Treatment Emergent Adverse Events (TEAEs) |
| Registry ID | NCT07298447 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:24.550Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07298447
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.